Tag: PAD
ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following rivaroxaban use
Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about the VOYAGER-PAD trial,...
Customising therapy in femoropopliteal revascularisation
Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based ther...
